Nutex Health Hits Record-Breaking Growth in Q4 2025, Cementing Its Position as a Leader in Healthcare
Nutex Health, a leading healthcare provider, has announced its fourth quarter and full year 2025 financial results, showcasing a remarkable 82% increase in total revenue to $875.3 million.
In a conference call held on March 6, 2026, Dr. Tom Vo, Founder and Chief Executive Officer of Nutex Health, highlighted the company's exceptional growth, operational discipline, and continued innovation as it advances its mission of delivering high-quality, concierge-level healthcare to the communities it serves.
The company's full year 2025 financial performance was marked by a significant increase in net income to $70.8 million compared to $52.1 million in 2024. Adjusted EBITDA, which includes the add back of stock-based compensation, rose to $259.6 million, up 152.6% from $102.8 million the prior year.
On the volume side, Nutex Health's hospitals recorded 188.3 thousand total patient visits, up 11.8% from 168.4 thousand in 2024. A notable 1.3% of this growth came from mature facilities, demonstrating their resilience and continued relevance in their markets.
The company's balance sheet also reflected a significant improvement, with the current portion of long-term debt decreasing slightly to $13.3 million, while net cash from operating activities reached $248.1 million for the 12 months ended December 25, 2025. Cash on hand grew dramatically to $186 million as of December 31, 2025, up from $41 million a year earlier.
However, Nutex Health did recognize a one-time $55 million revenue reduction related to the cumulative true-up of 18,950 arbitration claims that were deemed ineligible by arbitrators under the IDR process. The periods involved were July 24, 2024, when the company first started doing arbitration and IDR, through the end of December 2025.
Despite this one-time adjustment, Nutex Health's Q4 2025 results demonstrate its continued commitment to delivering high-quality healthcare services while maintaining a strong financial position. The company's record-breaking growth and operational discipline have cemented its position as a leader in the healthcare industry.
